To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
About This Bill
Committee
Latest Action · September 14, 2026
Referred to the House Committee on Energy and Commerce.